Le Chevalier T - Search Results

1

Phase I-II and pharmacokinetic study of a new fotemustine schedule in advanced non-small cell lung cancer.

Le Cesne A, Chabot G, Bérille J, Lucas C, Baud M, Gouyette A, Marty M, Le Chevalier T. Le Cesne A, et al. Among authors: le chevalier t. Lung Cancer. 1995 Aug;13(1):69-78. doi: 10.1016/0169-5002(95)00479-k. Lung Cancer. 1995. PMID: 8528641 Clinical Trial.

2

Impact of chemotherapy on survival in locally advanced non-small cell lung cancer: the Gustave-Roussy experience.

Le Cesne A, Le Chevalier T, Arriagada R. Le Cesne A, et al. Among authors: le chevalier t. Lung Cancer. 1995 Apr;12 Suppl 1:S79-85. doi: 10.1016/0169-5002(95)00423-x. Lung Cancer. 1995. PMID: 7551937 Review.

3

[Importance of the initial chemotherapy dose in the treatment of small cell lung carcinoma: therapeutic perspectives].

Le Chevalier T, Le Cesne A, Arriagada R. Le Chevalier T, et al. Among authors: le cesne a. Bull Cancer. 1995;82 Suppl 1:24s-28s. Bull Cancer. 1995. PMID: 7626850 Clinical Trial. French.

4

Cisplatin-fotemustine combination in inoperable non-small cell lung cancer: preliminary report of a French multicentre phase II trial.

Rivière A, Le Cesne A, Berille J, Baio S, Le Chevalier T. Rivière A, et al. Among authors: le chevalier t, le cesne a. Eur J Cancer. 1994;30A(5):587-90. doi: 10.1016/0959-8049(94)90525-8. Eur J Cancer. 1994. PMID: 8080671 Clinical Trial.

5

Phase II study of nitrosourea fotemustine as single-drug chemotherapy in poor-prognosis non-small-cell lung cancer.

Pujol JL, Monnier A, Berille J, Cerrina ML, Douillard JY, Rivière A, Grandgirard A, Gouva S, Bizzari JP, Le Chevalier T. Pujol JL, et al. Among authors: le chevalier t. Br J Cancer. 1994 Jun;69(6):1136-40. doi: 10.1038/bjc.1994.223. Br J Cancer. 1994. PMID: 8198982 Free PMC article. Clinical Trial.

6

Dealing with initial chemotherapy doses: a new basis for treatment optimisation in limited small-cell lung cancer.

Le Cesne A, Le Chevalier T, Arriagada R. Le Cesne A, et al. Among authors: le chevalier t. Ann Oncol. 1995;6 Suppl 3:S53-6. doi: 10.1093/annonc/6.suppl_3.s53. Ann Oncol. 1995. PMID: 8616117 Free article. Review.

7

Phase I/II study of paclitaxel plus cisplatin as first-line chemotherapy for advanced non-small cell lung cancer: preliminary results.

Belli L, LeChevalier T, Gottfried M, Adams D, Ruffie P, LeCesne A, Tete L, Pellae-Cosset B. Belli L, et al. Semin Oncol. 1995 Dec;22(6 Suppl 15):29-33. Semin Oncol. 1995. PMID: 8643967 Clinical Trial.

8

[New therapeutic strategies and current research in inoperable locally advanced non small-cell lung cancers (stage IIIB)].

Le Cesne A, Arriagada R, Grunenwald D, Baldeyrou P, Girard P, Bretel JJ, Le Chevalier T. Le Cesne A, et al. Among authors: le chevalier t. Bull Cancer. 1997 Apr;84(4):413-9. Bull Cancer. 1997. PMID: 9238166 Review. French.

9

[Dose-effect of chemotherapy in bronchial small-cell cancer].

de Crevoisier R, le Cesne A, le Chevalier T. de Crevoisier R, et al. Among authors: le chevalier t, le cesne a. Rev Mal Respir. 1997 Sep;14(4):269-75. Rev Mal Respir. 1997. PMID: 9411610 Review. French.

10

Docetaxel (Taxotere) plus cisplatin: an active and well-tolerated combination in patients with advanced non-small cell lung cancer.

Le Chevalier T, Monnier A, Douillard JY, Ruffie P, Sun XS, Belli L, Ibrahim N, Bougon N, Bérille J. Le Chevalier T, et al. Eur J Cancer. 1998 Dec;34(13):2032-6. doi: 10.1016/s0959-8049(98)00287-1. Eur J Cancer. 1998. PMID: 10070306 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

334 results

Search Page

Filters